[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of COVID-19].
Zhonghua Zhong Liu Za Zhi
; 42(3): 187-191, 2020 Mar 23.
Article
em Zh
| MEDLINE
| ID: mdl-32108460
ABSTRACT
Objective:
From December 2019, the new coronavirus pneumonia (COVID-19) broke out in Wuhan, Hubei, and spread rapidly to the nationwide. On January 20, 2020, the National Health Committee classified COVID-19 pneumonia as one of B class infectious diseases and treated it as class A infectious disease. During the epidemic period, the routine diagnosis and treatment of tumor patients was affected with varying degrees. In this special period, we performed the superiority of the multi-disciplinary team of diagnosis and treatment, achieved accurate diagnosis and treatment of patients with hepatobiliary malignant tumors, provided support for these patients with limited medical resources, and helped them to survive during the epidemic period.On the basis of fully understanding the new coronavirus pneumonia, the treatment strategy should be changed timely during the epidemic, and more appropriate treatment methods should be adopted to minimize the adverse effect of the epidemic on tumor treatment.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Infecção Hospitalar
/
Infecções por Coronavirus
/
Coronavirus
/
Pandemias
/
Neoplasias Hepáticas
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
País como assunto:
Asia
Idioma:
Zh
Ano de publicação:
2020
Tipo de documento:
Article